Summary: A derivative of luciferin, 4-methyl-ZMuciferin, was synthesized in low yield, and characterized by its ultraviolet and fluorescence spectra. The spectra of luciferin and its derivative are very similar. 4-MethylZMuciferin is a substrate of Photinus pyralis luciferase, and it causes light emission in luminometric assays.
Introduction
Firefly luciferase catalyses the ATP-dependent oxidative decarboxylation of D(-)-luciferin, accompanied by the production of light.
Firefly luciferin, Z)(-)-2-(6 / -hydroxy-2 / -benzothiazolyl)-2-thiazoline-4-carboxylic acid was first isolated in pure form from the American firefly Photinus pyralis in 1957 by Bitler & Me Elroy (1) . Luciferin was subsequently chemically synthesized and characterized by White et al. (2) .
Many structural analogues of luciferin have been synthesized (3 -7) . All are characterized by substitution of the carboxyl group or the phenoxide ion. However, since these two chemical groups are essential for luciferin light emission properties (8) , the synthesized derivatives are poor substrates or require post modifications (7, 9) .
With the aim of constructing luciferin-labelled macromolecules, in which the luciferin moiety is branched through a carbon spacer on carbon 4, we have investigated whether 4-methyl-ZMuciferin behaves as a substrate of luciferase. In this paper, we present the protocol for the synthesis of this compound, and describe its physico-chemical properties and its light emission properties during luciferasecatalysed oxidation. It was shown that the methylderivative possesses strong light emission properties, confirming that substitution on carbon 4 is suitable for linking to other biomolecules.
Materials and Methods
The products used for synthesis of 4-methyl-ZMuciferin and the solvents for its purification were purchased from Aldrichchimie, France.
Z>-Luciferin (Photinus pyralis), luciferase (Photinus pyralis;
8 U/mg) and ATP were purchased from Boehringer Mannheim, FRG.
Synthesis of 4-methyl-/)-luciferin
This compound was synthesized by a modification of the White & Me Capra procedure (1).
4-Methoxy 2-methylaniline is condensed with ethyloxalate to give the oxamate (I). This compound is converted to the thioamide with phosphorus pentasulphlde and hydrolysed without isolation to give the thiooxamic acid (II). Oxidation of (II) with alkaline ferricyanide gives the benzothiazole compound (III), which is converted into the amide (IV) by treatment with thionyl chloride, then ammonia. Dehydration with phosphorus oxychloride leads to the nitrile (V). Demethylation of (V) by pyridine hydrochloride gives the phenol (VI). Condensation of (VI) with D-cysteine gives a low yield of the required luciferin (VII).
Farace et al.r A new substrate of firefly luciferase Spectrometry Ultra-violet spectra were made at room temperature using a Uvikon 860 spectrophotometer (Kontron Instrument). Fluorescence spectra were made with a spectrofluorimeter JY 3D (Jobin Yvon) at room temperature. The buffer used in both cases was 20 mmol/1 TRIS-acetate, pH 7.75, containing 10 mmol/1 magnesium acetate.
Ethyl-N-(4-methoxy 2-methyl-phenyl) oxamate (I)
Ethyioxalate (1.5 mol) was heated to 120 °C. Amine (0.73 mol) was then added and the temperature of the mixture raised to 180°C for five minutes. After cooling the mixture in an ice bath, the precipitated solid was collected, then washed with ethanol and ether; m.p. 94 °C; yield 65%.
HPLC chromatography
We used the following HPLC system: column PROLABO SiC5 (250 χ 4mm); flow 0.6 ml/min; wavelength 270 nm. Eluant: 0.05 mol/1 ammonium acetate (pH 7.0), methanol, volume fraction 0.52.
Determination of enzyme activity
The acticities of luciferin and its derivative as substrates of luciferase were compared according to the modified procedure of Miska & Geiger (9) . The bioluminometer (Clinilumat LB 9502T) was from Berthold Wildbad, FRG. A solution containing 2.5 mg/1 luciferase and 10 mmol/1 ATP in 20 mmol/1 TRISacetate, pH 7.75, 10 mmol/1 Mg 2+ , 0.66 mmol/1 EDTA, 0.1 mmol/1 dithioerythritol, 0.01 g/1 NaN 3 and 0.1 g/1 bovine serum albumin, was preincubated at room temperature for 20 minutes. One hundred microlitres (100 μΐ) of this solution were then mixed with the same volume of diluted luciferin or luciferin derivative; light impulses were integrated for 10 seconds at 25 °C. Each enzyme substrate was assayed four times independently. Triplicate determinations were carried out for each assay and the coefficient of variation was expressed as a percentage of the mean value.
Results and Discussion

Synthesis of 4-methyl-/)-luciferin
Methyl luciferin was synthesized in 7 steps, each in fairly good yield, except for the last one. They are described on figure 1.
N-(4-Methoxy 2-methyl-phenyl)thiooxamic acid (II)
43 g of (I) were added to 0.9 1 of boiling xylene, followed by the addition of 14.5 g of phosphorus pentasulphide in small portions to the boiling solution. Reflux was continued for 2 hours. After cooling, the mixture was extracted with ten 150 ml portions of 1 mol/1 sodium hydroxide. The basic extracts were filtered, cooled to 0 C C and acidified with concentrated hydrochloric acid (200 ml). The precipitate was collected and washed with water. We used this crude material for the oxidation.
6-Methoxy-4-methyl-benzothiazole 2-carboxylic acid (HI)
Crude (II) was dissolved in 1 mol/1 sodium hydroxide (700 ml) and oxidized with potassium ferricyanide (200 g in 500 ml of water) by slow addition of the thioxamic acid to the ferricyanide solution, keeping the temperature of the mixture below 10 °C. The mixture was filtered and the solid collected. The solid was suspended in water with stirring, and acidified with concentrated hydrochloric acid. A brown solid was precipitated; m. p. 127 °C; yield 66% (from the oxamate); NMR (in DMSO): 7.65 and 7.2 ppm aromatic protons, 3.9 ppm OCH 3 , 2.7 ppm OCH 3 .
6-Methoxy-4-methyl-benzothiazole 2-carboxamide (IV)
0.117 mol of (III) and 150 ml of thionyl chloride were refluxed for two hours. The excess thionylchloride was removed and the remaining product was dissolved in 200 ml of methylene chloride. Gaseous ammonia was bubbled through the solution for 4 hours. The precipitate was filtered and washed with water to yield 10 g (40%) of a solid melting at 205.8 °C. 
2-Cyano-6-methoxy-4-methyl benzothiazole (V)
We heated a mixture of 0.022 mol of (V) with 30 ml of phosphorus oxychloride under reflux, until all the amide had dissolved (ca 15 min). The excess phosphorus oxychloride was removed as completely as possible. The residue was cooled, ether added and the solution was decomposed with 10 g/1 sodium bicarbonate solution. The pH was adjusted to 6 and the nitrile was extracted with chloroform.
The chloroform solution was washed with water, dried over magnesium sulphate, and the solvent evaporated to give 3 g of an oily product (yield 67%).
2-Cyano-6-hydroxy-4-methyl benzothiazole (VI)
Pyridine hydrochloride (20 g) was heated to 220 °C in an anhydrous atmosphere. Then (V) (1.5 g) was added in small portions. The mixture was heated with stirring at 220 °C for an hour. After cooling, the black solution was decomposed with a 100 g/1 sodium carbonate solution, taking care that the solution did not become strongly alkaline. The solid was then filtered.
For purification, the crude nitrile was dissolved in ethanol and passed through a column of charcoal (4 g) and celite (7 g).
Removal of the solvent gave 100 mg (7%) of (VI).
NMR (CD 3 COCD 3 ) 8.5 ppm OH, 7.4 and 7.1 ppm aromatic protons, 2.7 ppm CH 3 .
4-Methyl-D-luciferin (VII)
In a flask of low actinic glass (under a nitrogen atmosphere) 100 mg of Z)-cysteine hydrochloride and 6 ml of 1 g/1 sodium carbonate solution were mixed with stirring, followed by addition of 100 mg of (VI) in methanol (5 ml). A precipitate formed, then redissolved. After an hour the mixture was acidified with 1 mol/1 hydrochloric acid and kept at 0 °C overnight. Rapid filtration gave a pale yellow solid; yield 10 mg (6.5%). This product must be protected from light, oxygen and basic conditions.
Chemical characterization
The luciferin derivative was characterized by ultra-violet and fluorescence spectrophotometry (see spectra in figs. 2 and 3) . The UV spectrum of luciferin and its derivative are very similar, indicating that both molecules share the same aromatic structures. Furthermore, as shown in figure 2, we found that luciferin and 4-methyl-Z>-luciferin have the same absorption peak at 266 nm. The fluorometric analysis showed identical peaks of excitation and emission (tab. 1). However, we noted that the intensities for 4-methyl-Z)-luciferin were reduced in comparison with luciferin. In high performance liquid chromatography, the synthesized methylated derivative of luciferin was shown to be homogeneous, with a retention time very close to but greater than that of natural luciferin (data not shown). In our procedure, methyl-luciferin was not synthesized by modification of luciferin, but by a total synthesis from appropriate precursors. There is therefore no possibility that luciferin is present, i.e. light production in the enzymic assay cannot be due to or affected by traces of luciferin. The ability of methylluciferin to replace the natural substrate in an enzymic assay was investigated by incubating various amounts of luciferin or methyl-luciferin with fixed amounts of ATP and luciferase. Tensecond light impulse intensities are plotted on figure 4. This shows that the methylated derivative of luciferin is indeed a substrate of luciferase and that up to 1000 times the background level can be attained at 3.5 · 10~5 mol/1. Also, as for luciferin, (10) this is due to luciferase inhibition by oxyluciferin, a by-product of the reaction.
Chemical synthesis from ethyloxalate gives a modified derivative without contamination with the natural substrate, which is important for the comparison of the two substrates in the enzymic reaction. As a substrate for light production with luciferase, methyl-luciferin is highly efficient, although it is twenty times less efficient than luciferin. This demonstrates that an additional group in the carbon 4 does not prevent light emission. Substitution of the methyl group on the aromatic ring makes it possible to link luciferin to various molecules. We are now testing the properties of such substrates.
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